These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1916892)

  • 1. Maturation of the antibody response to a protein-coupled form of the organophosphorus toxin soman.
    Buenafe AC; Rittenberg MB
    Immunology; 1991 Aug; 73(4):398-406. PubMed ID: 1916892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis and fine specificity of antibodies against an organophosphorus hapten.
    Buenafe AC; Makowski FF; Rittenberg MB
    J Immunol; 1989 Jul; 143(2):539-45. PubMed ID: 2500482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining site specificity of monoclonal antibodies to the organophosphate hapten soman.
    Buenafe AC; Rittenberg MB
    Mol Immunol; 1987 May; 24(5):401-7. PubMed ID: 3657786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An organophosphorus hapten used in the preparation of monoclonal antibody and as an active immunization vaccine in the detoxication of soman poisoning.
    Jia P; Wang Y; Yu M; Wu J; Yang R; Zhao Y; Zhou L
    Toxicol Lett; 2009 May; 187(1):45-51. PubMed ID: 19429243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mechanisms of specific suppression of anti-hapten antibody response mediated by monoclonal anti-carrier antibody.
    Sumida T; Taniguchi M
    J Immunol; 1985 Jun; 134(6):3675-81. PubMed ID: 3157746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of immunogen design in induction of soman-specific monoclonal antibodies.
    Johnson JK; Cerasoli DM; Lenz DE
    Immunol Lett; 2005 Jan; 96(1):121-7. PubMed ID: 15585315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic memory to phosphocholine. IV. Hybridomas representative of Group I (T15-like) and Group II (non-T15-like) antibodies utilize distinct VH genes.
    Chang SP; Perlmutter RM; Brown M; Heusser CH; Hood L; Rittenberg MB
    J Immunol; 1984 Mar; 132(3):1550-5. PubMed ID: 6420466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purified protein derivative (PPD) as an immunogen carrier elicits high antigen specificity to haptens.
    De Silva BS; Egodage KL; Wilson GS
    Bioconjug Chem; 1999; 10(3):496-501. PubMed ID: 10346883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the group I and group II antibody response against PC-KLH in normal and T15 idiotype-suppressed BALB/c mice.
    Bruderer U; Aebersold R; Blaser K; Heusser CH
    Immunology; 1988 Jul; 64(3):385-90. PubMed ID: 3410491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The specificity of murine polyclonal and monoclonal antibodies to the haptenic drug chlorhexidine induced by chlorine-generated chlorhexidine-protein conjugates.
    Layton GT; Stanworth DR; Amos HE
    Clin Exp Immunol; 1987 Jul; 69(1):157-65. PubMed ID: 2443288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation of monoclonal antibodies against neurotoxic agent raised from an organophosphorus hapten and its characterization].
    Xu QH; Zhao YM; Rong KT
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Mar; 19(2):172-5. PubMed ID: 15151760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence and fine specificity analysis of primary 511 anti-phosphorylcholine antibodies.
    Feeney AJ; Thuerauf DJ
    J Immunol; 1989 Dec; 143(12):4061-8. PubMed ID: 2512348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of metabolism in the immunogenicity of drugs: production of antibodies to a horseradish peroxidase generated conjugate paracetamol.
    Chesham J; Davies GE
    Clin Exp Immunol; 1985 Aug; 61(2):224-31. PubMed ID: 2412741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hapten-carrier interactions and their role in the production of monoclonal antibodies against hydrophobic haptens.
    Fasciglione GF; Marini S; Bannister JV; Giardina B
    Hybridoma; 1996 Feb; 15(1):1-9. PubMed ID: 9064280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of IgG anti-carrier responses by IgG2 anti-hapten antibodies in mice.
    Coulie PG; Van Snick J
    Eur J Immunol; 1985 Aug; 15(8):793-8. PubMed ID: 4029257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of antigen-specific Th2 cell-dependent IgM and IgG1 production following norepinephrine depletion in vivo.
    Kohm AP; Sanders VM
    J Immunol; 1999 May; 162(9):5299-308. PubMed ID: 10228005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of soman-binding antibodies raised against soman analogs.
    Glikson M; Arad-Yellin R; Ghozi M; Raveh L; Green BS; Eshhar Z
    Mol Immunol; 1992; 29(7-8):903-10. PubMed ID: 1635561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of synthesis by Lumbricus terrestris of specific substances in response to an immunization with a synthetic hapten.
    Laulan A; Morel A; Lestage J; Delaage M; Châteaureynaud-Duprat P
    Immunology; 1985 Dec; 56(4):751-8. PubMed ID: 4077104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of anti-hapten antibody responses in vivo: memory, carrier-specific Lyt-2+ T cells can terminate antibody production without altering the peak of response.
    Kanellopoulos-Langevin C; Mathieson BJ; Perkins A; Maynard A; Asofsky R
    J Immunol; 1984 Apr; 132(4):1639-46. PubMed ID: 6199405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrolysis of organophosphorus nerve agent soman by the monoclonal antibodies elicited against an oxyphosphorane hapten.
    Yli-Kauhaluoma J; Humppi T; Yliniemelä A
    Acta Chem Scand (Cph); 1999 Jul; 53(7):473-9. PubMed ID: 10423832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.